AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Bill Tracker · New Jersey

A1617

CJ’s Law — kratom restrictions

Status

Pending

2026–2027

Proposal criminalizing manufacture, sale and possession of substances containing kratom. Not only synthetic 7-OH.

IntroducedJan 13, 2026 (done)
PassedNext step (current)
Signed— (upcoming)
Law in effect— (upcoming)

Type: Official legislature record
Substances: Kratom / 7-OH

Official text

Summary of official legislation

Proposal criminalizing manufacture, sale and possession of substances containing kratom. Not only synthetic 7-OH.

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: njleg.state.nj.us

Legislative history

January 13, 2026
Referred to Assembly Consumer Affairs.

Loading bill…